Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cells

Patients with obstructive sleep apnea (OSA) experience repetitive episodes of desaturation and resaturation of blood oxygen (known as intermittent hypoxia or IH), during sleep. We showed previously that IH induced excessive proliferation of rat vascular smooth muscle cells through upregulation of me...

Full description

Bibliographic Details
Main Authors: Yoji Kyotani, Asako Itaya‐Hironaka, Akiyo Yamauchi, Sumiyo Sakuramoto‐Tsuchida, Mai Makino, Shin Takasawa, Masanori Yoshizumi
Format: Article
Language:English
Published: Wiley 2018-05-01
Series:FEBS Open Bio
Subjects:
Online Access:https://doi.org/10.1002/2211-5463.12430
_version_ 1827987720539996160
author Yoji Kyotani
Asako Itaya‐Hironaka
Akiyo Yamauchi
Sumiyo Sakuramoto‐Tsuchida
Mai Makino
Shin Takasawa
Masanori Yoshizumi
author_facet Yoji Kyotani
Asako Itaya‐Hironaka
Akiyo Yamauchi
Sumiyo Sakuramoto‐Tsuchida
Mai Makino
Shin Takasawa
Masanori Yoshizumi
author_sort Yoji Kyotani
collection DOAJ
description Patients with obstructive sleep apnea (OSA) experience repetitive episodes of desaturation and resaturation of blood oxygen (known as intermittent hypoxia or IH), during sleep. We showed previously that IH induced excessive proliferation of rat vascular smooth muscle cells through upregulation of members of the epidermal growth factor family, especially epiregulin (EREG), and the erbB2 receptor. In this study, we exposed human coronary artery smooth muscle cells to IH and found that IH significantly increased the expression of EREG. IH increased the production of interleukin‐6 (IL‐6) in smooth muscle cells, and the addition of IL‐6 induced EREG expression. Small interfering RNA for IL‐6 or IL‐6 receptor attenuated the IH‐induced increase in EREG. IL‐6 may play a pivotal role in EREG upregulation by IH and consequently OSA‐related atherosclerosis.
first_indexed 2024-04-09T23:52:30Z
format Article
id doaj.art-6beaa8a64bf04daebb6eb0eaccca6605
institution Directory Open Access Journal
issn 2211-5463
language English
last_indexed 2024-04-09T23:52:30Z
publishDate 2018-05-01
publisher Wiley
record_format Article
series FEBS Open Bio
spelling doaj.art-6beaa8a64bf04daebb6eb0eaccca66052023-03-17T06:46:13ZengWileyFEBS Open Bio2211-54632018-05-018586887610.1002/2211-5463.12430Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cellsYoji Kyotani0Asako Itaya‐Hironaka1Akiyo Yamauchi2Sumiyo Sakuramoto‐Tsuchida3Mai Makino4Shin Takasawa5Masanori Yoshizumi6Department of Pharmacology Nara Medical University Kashihara JapanDepartment of Biochemistry Nara Medical University Kashihara JapanDepartment of Biochemistry Nara Medical University Kashihara JapanDepartment of Biochemistry Nara Medical University Kashihara JapanDepartment of Biochemistry Nara Medical University Kashihara JapanDepartment of Biochemistry Nara Medical University Kashihara JapanDepartment of Pharmacology Nara Medical University Kashihara JapanPatients with obstructive sleep apnea (OSA) experience repetitive episodes of desaturation and resaturation of blood oxygen (known as intermittent hypoxia or IH), during sleep. We showed previously that IH induced excessive proliferation of rat vascular smooth muscle cells through upregulation of members of the epidermal growth factor family, especially epiregulin (EREG), and the erbB2 receptor. In this study, we exposed human coronary artery smooth muscle cells to IH and found that IH significantly increased the expression of EREG. IH increased the production of interleukin‐6 (IL‐6) in smooth muscle cells, and the addition of IL‐6 induced EREG expression. Small interfering RNA for IL‐6 or IL‐6 receptor attenuated the IH‐induced increase in EREG. IL‐6 may play a pivotal role in EREG upregulation by IH and consequently OSA‐related atherosclerosis.https://doi.org/10.1002/2211-5463.12430epiregulininterleukin‐6intermittent hypoxia
spellingShingle Yoji Kyotani
Asako Itaya‐Hironaka
Akiyo Yamauchi
Sumiyo Sakuramoto‐Tsuchida
Mai Makino
Shin Takasawa
Masanori Yoshizumi
Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cells
FEBS Open Bio
epiregulin
interleukin‐6
intermittent hypoxia
title Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cells
title_full Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cells
title_fullStr Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cells
title_full_unstemmed Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cells
title_short Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cells
title_sort intermittent hypoxia induced epiregulin expression by il 6 production in human coronary artery smooth muscle cells
topic epiregulin
interleukin‐6
intermittent hypoxia
url https://doi.org/10.1002/2211-5463.12430
work_keys_str_mv AT yojikyotani intermittenthypoxiainducedepiregulinexpressionbyil6productioninhumancoronaryarterysmoothmusclecells
AT asakoitayahironaka intermittenthypoxiainducedepiregulinexpressionbyil6productioninhumancoronaryarterysmoothmusclecells
AT akiyoyamauchi intermittenthypoxiainducedepiregulinexpressionbyil6productioninhumancoronaryarterysmoothmusclecells
AT sumiyosakuramototsuchida intermittenthypoxiainducedepiregulinexpressionbyil6productioninhumancoronaryarterysmoothmusclecells
AT maimakino intermittenthypoxiainducedepiregulinexpressionbyil6productioninhumancoronaryarterysmoothmusclecells
AT shintakasawa intermittenthypoxiainducedepiregulinexpressionbyil6productioninhumancoronaryarterysmoothmusclecells
AT masanoriyoshizumi intermittenthypoxiainducedepiregulinexpressionbyil6productioninhumancoronaryarterysmoothmusclecells